science top stories popular news  

Daily non-political popular news in brief.

Cancer risk in HIV, transplant patients

07-06-2007 · EurekAlert!

HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to research from the University of New South Wales (UNSW). The land mark paper has been published in The Lancet.

Read more »

Keywords: cancer, risk, hiv, transplant, patients, patient

« Previous | Next »

Similar news on "Cancer risk in HIV, transplant patients":

  1. Rhode Island Hospital study identifies high-risk patient populations for MRSA carriage
    04-16-2007 · EurekAlert!
    A Rhode Island Hospital study found that patients in long-term elder care and HIV-infected outpatients appear to be high-risk groups for carriage of MRSA.
    Similar news · Read more »
  2. Gene that governs toxin production in deadly mold found
    04-12-2007 · EurekAlert!
    For the growing number of people with diminished immune systems -- cancer patients, transplant recipients, those with HIV/AIDS -- infection by a ubiquitous mold known as Aspergillus fumigatus can be a death sentence.
    Similar news · Read more »
  3. Preventing graft-vs.-host disease after bone marrow transplant -- without toxicity
    12-11-2006 · EurekAlert!
    Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
    Similar news · Read more »
  4. Advanced therapy offers cure for relapsed cancer patient
    07-25-2007 · EurekAlert!
    Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine study by Lawrence Einhorn, M.D.; Stephen Williams, M.D.; Rafat Abonour, M.D., and colleagues published in the July 26 issue of the New England Journal of Medicine. Although the number of relapsed testicular cancer patients in the US is small, the IU Simon Cancer Center treats a majority of them.
    Similar news · Read more »
  5. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
    12-11-2006 · EurekAlert!
    Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
    Similar news · Read more »
  6. UBC researcher finds new way to treat devastating fungal infections
    03-05-2007 · EurekAlert!
    Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
    Similar news · Read more »
  7. Flaws in colonoscopies may increase risk of colon cancer
    05-23-2007 · EurekAlert!
    Colonoscopies are considered the gold standard for detecting colon cancer, the second leading cause of cancer deaths in the United States. Research presented today at Digestive Disease Week 2007 discusses contributing factors that could prevent patients from getting optimal results from their colonoscopy, including age of the patient, location of the screening and proper technician training. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
    Similar news · Read more »
  8. JCI table of contents: Aug. 23, 2007
    08-23-2007 · EurekAlert!
    This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Aug. 23, 2007, in the JCI, including: New weapon to fight leukemia; Inhaling helps heal liver transplant recipients; Being fat needn't be all bad news; DNA provides clues to outcome in patients with liver cancer; Risk factor for heart disease: Just say NO; Building muscle requires Foxo1; and others.
    Similar news · Read more »
  9. PSA doubling predicts prostate cancer recurrence
    04-09-2007 · EurekAlert!
    A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. Doubling time is defined as the duration for PSA levels in the blood to increase by 100 percent.
    Similar news · Read more »
  10. Caring for the sick now a public health priority for developing countries
    05-09-2007 · EurekAlert!
    The epidemic rates of chronic disease such as diabetes, stroke and heart disease, as well as cancer and HIV/AIDS in many low-middle income countries, means they are experiencing a greater need for palliative care than most western countries. Palliative care is commonly used in developed countries to improve the quality of life of patients with life-threatening illnesses, through strategies aimed mainly at pain relief.
    Similar news · Read more »